Researchers find that patients with cancer who are severely immunocompromised may benefit from a more frequent seasonal vaccine schedule.

by Sandra Gordon

Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.

by Kyle Bagenstose

Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.

by Thomas Celona

Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

by Anna Goshua

Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

by Kevin McLaughlin